Qube Research & Technologies Ltd - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2021$366,000
+48.2%
88,984
-1.0%
0.01%
+50.0%
Q2 2020$247,000
+488.1%
89,883
+402.3%
0.00%
+100.0%
Q1 2020$42,000
-76.9%
17,895
-53.7%
0.00%
-66.7%
Q4 2019$182,00038,6600.01%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders